| Dr Alicia Ann Shields, DO | |
|
2300 Computer Rd Ste E25, Willow Grove, PA 19090-1737 | |
| (215) 366-1160 | |
| (215) 366-1141 |
| Full Name | Dr Alicia Ann Shields |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 11 Years |
| Location | 2300 Computer Rd Ste E25, Willow Grove, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629416235 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | OS018704 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).
UK scientists are to help tackle TB and malaria in the developing world through their leadership of two major international research projects.
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).
A new national study has found that inducing labor in first-time mothers at 39 weeks can help prevent cesarean births and high blood pressure.
› Verified 8 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538119029 PECOS PAC ID: 3274437736 Enrollment ID: O20040114000013 |
News Archive
Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).
UK scientists are to help tackle TB and malaria in the developing world through their leadership of two major international research projects.
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).
A new national study has found that inducing labor in first-time mothers at 39 weeks can help prevent cesarean births and high blood pressure.
› Verified 8 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).
UK scientists are to help tackle TB and malaria in the developing world through their leadership of two major international research projects.
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).
A new national study has found that inducing labor in first-time mothers at 39 weeks can help prevent cesarean births and high blood pressure.
› Verified 8 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1316189855 PECOS PAC ID: 3274437736 Enrollment ID: O20091218000204 |
News Archive
Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).
UK scientists are to help tackle TB and malaria in the developing world through their leadership of two major international research projects.
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).
A new national study has found that inducing labor in first-time mothers at 39 weeks can help prevent cesarean births and high blood pressure.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alicia Ann Shields, DO 2300 Computer Rd Ste E25, Willow Grove, PA 19090-1737 Ph: (215) 366-1160 | Dr Alicia Ann Shields, DO 2300 Computer Rd Ste E25, Willow Grove, PA 19090-1737 Ph: (215) 366-1160 |
News Archive
Massachusetts General Hospital (MGH) researchers have identified what may be a major factor behind the increased risk of two adverse outcomes in pregnancies conceived through in vitro fertilization (IVF).
UK scientists are to help tackle TB and malaria in the developing world through their leadership of two major international research projects.
The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.
A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).
A new national study has found that inducing labor in first-time mothers at 39 weeks can help prevent cesarean births and high blood pressure.
› Verified 8 days ago
Sherry L Blumenthal, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2701 Blair Mill Rd, Suite C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Frank Theodore Sandsorum Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2300 Computer Rd, Ste E25, Willow Grove, PA 19090 Phone: 215-659-8080 Fax: 215-659-0977 | |
Vahideh T Ameri, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 735 Fitzwatertown Rd, Suite 4, Willow Grove, PA 19090 Phone: 215-914-4400 Fax: 215-657-4887 | |
Patricia Ann Sullivan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2701 Blair Mill Rd Ste C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Joseph James Murphy Iii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2300 Computer Rd Ste E25, Willow Grove, PA 19090 Phone: 215-366-1160 Fax: 215-672-6853 | |
Jessica M. Klemens, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2701 Blair Mill Rd, Suite C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Dr. Elizabeth Burton, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3941 Commerce Ave, Willow Grove, PA 19090 Phone: 215-481-4000 |